Rapid fibrinogen test during aortic dissection surgery
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This trial tests a new device that quickly measures fibrinogen (a protein that helps blood clot) from a small blood sample during surgery for type A aortic dissection. It aims to help doctors make faster decisions about blood clotting treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are having surgery for a type A aortic dissection (a tear in the main artery from the heart).
- You will need a routine TEG test (a blood clotting check) during surgery.
- You will receive fibrinogen concentrate (a medicine to help blood clot) during surgery.
- You do not need a heart-lung machine (ECMO) after surgery.
- You (or your family) can sign a consent form to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational treatment called INTERCEPT Fibrinogen Complex (IFC) for people with severe bleeding after a traumatic injury. The treatment helps restore a key blood-clotting protein to try to stop the bleeding and improve survival.
This trial checks if a fast bedside test for fibrinogen (a protein that helps blood clot) can help guide treatment for trauma patients who are actively bleeding. It may lead to better care in the emergency department.
This trial tests whether giving a personalized dose of fibrinogen, a protein that helps blood clot, after heart surgery reduces bleeding and the need for blood transfusions. It aims to improve recovery for patients who need fibrinogen after being on a heart-lung machine.
This trial tests whether using platelet-rich plasma (a concentration of your own blood's healing cells) during open surgery for type A aortic dissection can improve recovery and reduce complications. If you qualify, you would receive this extra treatment during your surgery.
This study tests a quick bedside measurement of how well the drug tranexamic acid works to prevent bleeding during heart surgery. It may help doctors give the right dose to reduce blood loss.
This trial tests whether using artificial intelligence to guide treatment choices can improve recovery in people with a sudden tear in the main artery (aortic dissection). All participants will receive emergency surgery, but the AI may help doctors tailor the approach to each person's condition, potentially reducing complications.
Hear when a new Hypofibrinogenemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.